MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6602-337-346$20.00
Mol Pharmacol 66:337-346, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gray, T.
Right arrow Articles by Langenbach, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gray, T.
Right arrow Articles by Langenbach, R.

Interleukin-1{beta}–Induced Mucin Production in Human Airway Epithelium Is Mediated by Cyclooxygenase-2, Prostaglandin E2 Receptors, and Cyclic AMP-Protein Kinase A Signaling

Thomas Gray, Paul Nettesheim, Charles Loftin1, Ja-Seok Koo2, James Bonner, Shyamal Peddada, and Robert Langenbach

Laboratories of Molecular Carcinogenesis (T.G., C.L., R.L.), Pulmonary Pathobiology (P.N., J.B.), and Biostatistics Branch (S.P.), National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina.

We reported recently that interleukin (IL)-1{beta} exposure resulted in a prolonged increase in MUC5AC mucin production in normal, well differentiated, human tracheobronchial epithelial (NHTBE) cell cultures, without significantly increasing MUC5AC mRNA (Am J Physiol 286:L320–L330, 2004). The goal of the present study was to elucidate the signaling pathways involved in IL-1{beta}–induced MUC5AC production. We found that IL-1{beta} increased cyclooxygenase-2 (COX-2) mRNA expression and prostaglandin (PG) E2 production and that the COX-2 inhibitor celecoxib suppressed IL-1{beta}–induced MUC5AC production. Addition of exogenous PGE2 to NHTBE cultures also increased MUC5AC production and IL-1{beta}–induced Muc5ac hypersecretion in tracheas from wild-type but not from COX-2–/– mice. NHTBE cells expressed all four E-prostanoid (EP) receptor subtypes and misoprostol, an EP2 and EP4 agonist, increased MUC5AC production, whereas sulprostone, an EP1 and EP3 agonist, did not. Furthermore, specific protein kinase A (PKA) inhibitors blocked IL-1{beta} and PGE2-induced MUC5AC production. However, neither inhibition of epidermal growth factor receptor (EGFR) activation with the tyrosine kinase inhibitor 4-(3-chloroanilino)-6,7-dimethoxyquinazoline HCl (AG-1478) or EGFR blocking antibody nor inhibition of extracellular signal-regulated kinase/P-38 mitogen activated protein kinases with specific inhibitors blocked IL-1{beta} stimulation of MUC5AC mucin production. We also observed that tumor necrosis factor (TNF)-{alpha}, platelet activating factor (PAF), and lipopolysaccharide (LPS) induced COX-2 and increased MUC5AC production that was blocked by celecoxib, suggesting a common signaling pathway of inflammatory mediator-induced MUC5AC production in NHTBE cells. We conclude that the induction of MUC5AC by IL-1{beta}, TNF-{alpha}, PAF, and LPS involves COX-2– generated PGE2, activation of EP2 and/or EP4 receptor(s), and cAMP-PKA–mediated signaling.


Received November 17, 2003; accepted May 13, 2004

Address correspondence to: Thomas Gray, Laboratory of Molecular Carcinogenesis, MD C4–09, PO Box 12233, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709. E-mail: grayt{at}niehs.nih.gov




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. R. White, B. M. Fischer, B. A. Marroquin, and R. Stern
Interleukin-1{beta} mediates human airway epithelial cell migration via NF-{kappa}B
Am J Physiol Lung Cell Mol Physiol, December 1, 2008; 295(6): L1018 - L1027.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
S C Mastbergen, J W J Bijlsma, and F P J G Lafeber
Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2
Ann Rheum Dis, January 1, 2008; 67(1): 52 - 58.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. D. N'Guessan, B. Temmesfeld-Wollbruck, J. Zahlten, J. Eitel, S. Zabel, B. Schmeck, B. Opitz, S. Hippenstiel, N. Suttorp, and H. Slevogt
Moraxella catarrhalis induces ERK- and NF-{kappa}B-dependent COX-2 and prostaglandin E2 in lung epithelium
Eur. Respir. J., September 1, 2007; 30(3): 443 - 451.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. Yoshida and R. M. Tuder
Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
Physiol Rev, July 1, 2007; 87(3): 1047 - 1082.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
V. C. Sandulache, J. B. Chafin, H.-S. Li-Korotky, T. D. Otteson, J. E. Dohar, and P. A. Hebda
Elucidating the Role of Interleukin 1beta and Prostaglandin E2 in Upper Airway Mucosal Wound Healing
Arch Otolaryngol Head Neck Surg, April 1, 2007; 133(4): 365 - 374.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Murakami, H. Kohsaka, H. Kitasato, and T. Akahoshi
Lipopolysaccharide-Induced Up-Regulation of Triggering Receptor Expressed on Myeloid Cells-1 Expression on Macrophages Is Regulated by Endogenous Prostaglandin E2
J. Immunol., January 15, 2007; 178(2): 1144 - 1150.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Sabo-Attwood, M. Ramos-Nino, J. Bond, K. J. Butnor, N. Heintz, A. D. Gruber, C. Steele, D. J. Taatjes, P. Vacek, and B. T. Mossman
Gene Expression Profiles Reveal Increased mClca3 (Gob5) Expression and Mucin Production in a Murine Model of Asbestos-Induced Fibrogenesis
Am. J. Pathol., November 1, 2005; 167(5): 1243 - 1256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W. Wu, R. A. Silbajoris, Y. E. Whang, L. M. Graves, P. A. Bromberg, and J. M. Samet
p38 and EGF receptor kinase-mediated activation of the phosphatidylinositol 3-kinase/Akt pathway is required for Zn2+-induced cyclooxygenase-2 expression
Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L883 - L889.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
K. F. Chung
Evaluation of Selective Prostaglandin E2 (PGE2) Receptor Agonists as Therapeutic Agents for the Treatment of Asthma
Sci. Signal., September 27, 2005; 2005(303): pe47 - pe47.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Clayton, E. Holland, L. Pang, and A. Knox
Interleukin-1{beta} Differentially Regulates {beta}2 Adrenoreceptor and Prostaglandin E2-mediated cAMP Accumulation and Chloride Efflux from Calu-3 Bronchial Epithelial Cells: ROLE OF RECEPTOR CHANGES, ADENYLYL CYCLASE, CYCLO-OXYGENASE 2, AND PROTEIN KINASE A
J. Biol. Chem., June 24, 2005; 280(25): 23451 - 23463.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-N. Cho, J. Y. Choi, C.-H. Kim, S. J. Baek, K. C. Chung, U. Y. Moon, K.-S. Kim, W.-J. Lee, J. S. Koo, and J.-H. Yoon
Prostaglandin E2 Induces MUC8 Gene Expression via a Mechanism Involving ERK MAPK/RSK1/cAMP Response Element Binding Protein Activation in Human Airway Epithelial Cells
J. Biol. Chem., February 25, 2005; 280(8): 6676 - 6681.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics